SESSION CHAIR

 

Senior Lecturer

Head of the Bioprocess and Biochemical Engineering (BioProChem) group

University of Surrey

 

DR. IR. EIRINI VELLIOU

 

Dr Eirini Velliou is Senior Lecturer (Associate Professor) of Bioprocess & Tissue Engineering, Principal Investigator and Founder of the Bioprocess and Biochemical Engineering group (BioProChem) in the Department of Chemical and Process Engineering at the University of Surrey. Her research focus falls within the engineering and validation of novel biomaterial based in vitro platforms for studying various biological systems and diseases, i.e., cancer, stem cells expansion and differentiation, formulation and communication of bacterial communities and bacterial-host interactions. Furthermore, s

Keynote Speakers

 

PROFESSOR TREVOR DALE

Director of Technology Cardiff School of Biosciences

"The practical challenges of using organoids in drug discovery"

READ MORE

Professor John Greenman

PROFESSOR OF TUMOR IMMUNOLOGY

"Patient tissue on chip – a personalized medicine option?"

READ MORE

Professor Stephen Evans

Director of Research and Innovation & Head of Molecular and Nanoscale Physics Group - Leeds University

"Cells Under Stress: Microfluidic Determination of Single Cell Behavior and it's Potential for Aiding Diagnosis and Treatment."

READ MORE

The Presenters

 

Dr Dania Movia

Senior Research Fellow

Trinity College Dublin

"Multilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs"

Dr Beate Rinner

Assistant Professor

Medizinische Universität Graz

"Metastatic melanoma during pregnancy - MUG-Mel3 cell line - an in vitro model"

Dr Karen Pilkington

Associate Head of Research

School of Health Sciences and Social Work, University of Portsmouth

"Interim findings from the SAToRI-BTR (A Systematic Approach To Review of In vitro models in Brain Tumour Research) project."

Dr Suzanne Randle

AstraZeneca, Cambridge UK

"Recent developments in in vitro models to assess haemtox risk of novel cancer therapeutics"

REGISTER TODAY